Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone

Fertility and Sterility

Volumn 69, Issue 5, 1998, Pages 831-835

  Sills, E Scott ^a,b   Schattman, Glenn L ^a   Veeck, Lucinda L ^a   Liu, Hung Ching ^a   Prasad, Monica ^a,c   Rosenwaks, Zev ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b Center for Reproductive Health   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Controlled ovarian hyperstimulation; FSH; HMG; Ovarian response

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; PROGESTERONE; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DOWN REGULATION; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HORMONE RESPONSE; HUMAN; HUMAN CELL; HYPOPHYSIS; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SUPEROVULATION;

ADULT; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; MENOTROPINS; PREGNANCY;

EID: 0032079510     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00046-6     Document Type: Article

References (24)

1. 1. Fevold HL. Synergism of the follicle stimulating and luteinizing hormone in producing estrogen secretion. Endocrinology 1941;28:33-6.
2. 2. Abbasi R, Kenigsberg D, Danforth D, Falk RJ, Hodgen GD. Cumulative ovulation induction in human menopausal gonadotropin/human chorionic gonadotropin-treated monkeys: "step-up" versus "step-down" regimens. Fertil Steril 1987;47:1019-24.
3. 3. Jennings JC, Moreland K, Peterson CM. In vitro fertilisation: a review of drug therapy and clinical management. Drugs 1996;52:313-43.
4. 4. Damario MA, Davis OK, Rosenwaks Z. The endocrinology of the assisted reproductive technologies. Curr Opin Endocrinol Diabetes 1995;2:493-9.
5. 5. Veeck LL. Oocyte assessment and biological performance. Ann NY Acad Sci 1988;541:259-74.
6. 6. Palermo GD, Schlegel PN, Colombero LT, Zaninovic N, Rosenwaks Z. Aggressive sperm immobilization prior to intracytoplasmic sperm injection with immature spermatozoa improves fertilization and pregnancy rates. Hum Reprod 1996;11:1023-9.
7. 7. Society for Assisted Reproductive Technology and The American Society for Reproductive Medicine. Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertil Steril 1996;66:697-705.
8. 8. Pieters MHEC, Dumoulin JCM, Englehart CM, Bras M, Evers JLH, Geraedts JPM. Immaturity and aneuploidy in human oocytes after different stimulation protocols. Fertil Steril 1991;56:306-10.
9. 9. Jacobson A, Marshall JR. Ovulatory response rate with human menopausal gonadotropins of varying FSH-LH ratios. Fertil Steril 1969;20:171-5.
10. 10. Edelstein MC, Brzyski RG, Jones GS, Simonetti S, Muasher SJ. Equivalency of human menopausal gonadotropin and follicle stimulating hormone after gonadotropin-releasing hormone suppression. Fertil Steril 1990;53:103-6.
11. 11. Lavy G, Pellicer A, Diamond MP, DeCherney AH. Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study. Fertil Steril 1988;50:74-8.
12. 12. Polan ML, Daniele A, Russell JB, DeCherney AH. Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels with discernible differences in granulosa-luteal cell function. J Clin Endocrinol Metab 1986;63:1284-91.
13. 13. Soccia B, Blumenthal P, Wagner C, Prins G, Scommenga A, Marnt EL. Comparison of urinary human follicle stimulating hormone and human menopausal gonadotropins for ovarian stimulation in an in vitro fertilization program. Fertil Steril 1987;48:446-9.
14. 14. Tanbo T, Dale PO, Ejekshus E, Harig E, Abyholm T. Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome. Fertil Steril 1990;53:798-803.
15. 15. Westergaard LG, Erb K, Lauersen S, Rasmussen PE, Rex S. The effect of human menopausal gonadotropin and highly purified, urine derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotropic women. Hum Reprod 1996;11:1209-13.
16. 16. Daya S, Gunby J, Hughes EG, Collins JA, Sagle MA. Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis. Fertil Steril 1995;64:347-54.
17. 17. Stanger J, Yovich JJ. Reduced in vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985;92:385-93.
18. 18. Howles C, Macnamee MC, Edwards RG. Follicular development and early luteal function of conception and non-conception cycles after human in vitro fertilization: endocrine correlates. Hum Reprod 1987;2:17-21.
19. 19. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev 1985;6:371-99.
20. 20. Schreiber JR, Reed R, Ross GT. A receptor-like testosterone-binding protein in ovaries from estrogen-stimulated hypophysectomized immature female rats. Endocrinology 1976;98:1206-13.
21. 21. Mercan R, Mayer JF, Walker D, Jones S, Oehninger S, Toner JP, et al. Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotropin combination. Hum Reprod 1997;12:1886-9.
22. 22. Balasch J, Miro F, Burzaco I, Casamitjana R, Civico S, Ballesca JL, et al. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotropic hypogonadism and using recombinant human follicle stimulating hormone. Hum Reprod 1995;10:1678-83.
23. 23. Fox R, Ekeroma A, Wardle P. Ovarian response to purified FSH in infertile women with long-standing hypogonadotropic hypogonadism. Aust NZ J Obstet Gynaecol 1997;37:92-4.
24. 24. Chappel SC, Howels C. Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod 1991;6:1206-12.